100 related articles for article (PubMed ID: 11347008)
1. [Clinical and economic aspects of chronic coronary restenosis: potential advantage of intracoronary brachytherapy].
Schiele TM; Siebert U; Cohen D; Klauss V
Dtsch Med Wochenschr; 2001 Apr; 126(15):440-4. PubMed ID: 11347008
[No Abstract] [Full Text] [Related]
2. [Intracoronary gamma brachytherapy significantly lowers the restenosis rate after PTCA and stent implantation].
Strnad V
Strahlenther Onkol; 2002 Jan; 178(1):51. PubMed ID: 11977393
[No Abstract] [Full Text] [Related]
3. Endovascular brachytherapy in coronary arteries: the Rotterdam experience.
Coen VL; Knook AH; Wardeh AJ; van der Giessen WJ; De Pan C; Sipkema D; Marijnissen JP; Sabaté M; den Boer A; Serruys PW; Levendag PC
Cardiovasc Radiat Med; 2000; 2(1):42-50. PubMed ID: 11229062
[TBL] [Abstract][Full Text] [Related]
4. [Endoluminal irradiation of coronary arteries: economic aspects before clinical safety?].
Baer FM; Erdmann E
Dtsch Med Wochenschr; 2001 Apr; 126(15):439. PubMed ID: 11347007
[No Abstract] [Full Text] [Related]
5. [New strategies in the treatment of restenosis].
von Hodenberg E; Tost B; Scheffold T
Z Kardiol; 2000; 89 Suppl 7():19-22. PubMed ID: 11098555
[TBL] [Abstract][Full Text] [Related]
6. Medical economic considerations of coronary stenting.
Szucs TD
Schweiz Med Wochenschr; 1999 Nov; 129(45):1701-11. PubMed ID: 10595380
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization: results from the TAXUS-IV Trial.
Bakhai A; Stone GW; Mahoney E; Lavelle TA; Shi C; Berezin RH; Lahue BJ; Clark MA; Lacey MJ; Russell ME; Ellis SG; Hermiller JB; Cox DA; Cohen DJ;
J Am Coll Cardiol; 2006 Jul; 48(2):253-61. PubMed ID: 16843171
[TBL] [Abstract][Full Text] [Related]
8. [Coronary physiology and its usefulness for the interventionist cardiologist: invasive measurement of coronary flow-pressure].
Barrera-Ramírez CF; Escaned J
Arch Cardiol Mex; 2005; 75(3):335-49. PubMed ID: 16294824
[TBL] [Abstract][Full Text] [Related]
9. Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials.
Taira DA; Seto TB; Siegrist R; Cosgrove R; Berezin R; Cohen DJ
Am Heart J; 2003 Mar; 145(3):452-8. PubMed ID: 12660668
[TBL] [Abstract][Full Text] [Related]
10. Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.
Reynolds MR; Neil N; Ho KK; Berezin R; Cosgrove RS; Lager RA; Sirois C; Johnson RG; Cohen DJ
Am Heart J; 2003 Feb; 145(2):334-42. PubMed ID: 12595853
[TBL] [Abstract][Full Text] [Related]
11. Cost analysis from two randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in high-risk patients with coronary artery disease.
Elezi S; Dibra A; Folkerts U; Mehilli J; Heigl S; Schömig A; Kastrati A
J Am Coll Cardiol; 2006 Jul; 48(2):262-7. PubMed ID: 16843172
[TBL] [Abstract][Full Text] [Related]
12. [Intracoronary brachytherapy against restenosis after percutaneous transluminal coronary angioplasty].
Holm AM; Haunsø S; Hansen PR
Ugeskr Laeger; 1999 Feb; 161(6):802. PubMed ID: 10028887
[No Abstract] [Full Text] [Related]
13. Randomized blinded clinical trial of intracoronary brachytherapy with 90Sr/Y beta-radiation for the prevention of restenosis after stent implantation in native coronary arteries in diabetic patients.
Syeda B; Schukro C; Kirisits C; Lang I; Siostrzonek P; Gottsauner-Wolf M; Pokrajac B; Schmid R; Yahya N; Pötter R; Glogar D
Radiother Oncol; 2006 Jan; 78(1):60-6. PubMed ID: 16309769
[TBL] [Abstract][Full Text] [Related]
14. [Can radiotherapy reduce the frequency of restenosis after coronary angioplasty?].
Langberg CW; Solheim S; Hagen S
Tidsskr Nor Laegeforen; 2000 Feb; 120(6):707-10. PubMed ID: 10806885
[TBL] [Abstract][Full Text] [Related]
15. Clinical trials of intracoronary gamma radiation therapy for in-stent restenosis.
Cha DH; Ajani AE; Cheneau E; Waksman R
J Invasive Cardiol; 2002 Jul; 14(7):432-7. PubMed ID: 12082202
[TBL] [Abstract][Full Text] [Related]
16. Intracoronary brachytherapy for the prevention of restenosis after percutaneous coronary revascularization.
Sheppard R; Eisenberg MJ; Donath D; Meerkin D
Am Heart J; 2003 Nov; 146(5):775-86. PubMed ID: 14597925
[TBL] [Abstract][Full Text] [Related]
17. Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.
Hlatky MA; Boothroyd DB; Melsop KA; Brooks MM; Mark DB; Pitt B; Reeder GS; Rogers WJ; Ryan TJ; Whitlow PL; Wiens RD
Circulation; 2004 Oct; 110(14):1960-6. PubMed ID: 15451795
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
[TBL] [Abstract][Full Text] [Related]
19. [Intracoronary brachytherapy after PTCA: current clinical position].
Silber S
Dtsch Med Wochenschr; 1999 Dec; 124(49):1491-5. PubMed ID: 10629668
[No Abstract] [Full Text] [Related]
20. Intracoronary brachytherapy: an evolving modality for treatment of restenosis following percutaneous coronary intervention.
Srinivas VS; Williams DO; Chougale P; Shearer D
Med Health R I; 2001 Feb; 84(2):51-4. PubMed ID: 11272660
[No Abstract] [Full Text] [Related]
[Next] [New Search]
